Irina Haivas is a Principal on the investment team based in London. She leads on sourcing, diligence and managing Atomico’s partnerships in frontier technologies and healthcare / bio, as well as enterprise. She focuses on companies that leverage data and advanced technologies such as AI and machine learning, biology, robotics, VR/AR, new materials, or next generation computing across industries and applications.
Irina is passionate about businesses and products with technical or design moats, that have potential to drive deep transformations of industries or behaviours. She looks to partner with bold, mission-driven founders that use first principles to push the boundaries of the status quo, and tackle high-stakes opportunities, such as health, biology, sustainability, future of work, diversity, security, or human potential.
Before joining Atomico, Irina was a growth investor at GHO Capital Partners, where she invested in B2B service, enterprise software, and big data analytics at the intersection of technology with life sciences and healthcare. Before that, Irina was part of the leadership team of Bain & Co. in Europe and the U.S., where she worked directly both with private equity firms on investment diligence, as well as with corporates on Innovation and Product, Go-to-Market, BD and acquisitions, and organisation scale-up. While at Bain she seconded in an operational role at Medtronic, one of the world’s largest medical engineering companies.
Irina is a former surgeon, having studied medicine at Freiburg University in Germany and Iasi Medical University in Romania. She was a surgical fellow at Harvard Medical School before completing an MSc (Dist) in International Health Policy at London School of Economics.
Irina speaks Romanian, English, advanced German, and conversational French.